Company / Return on Assets (ROA)
Elicio Therapeutics, Inc. Return on Assets (ROA) History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-103.4%
FY2022
5-year range
-103.4% / -83.0%
FY2021-FY2022
Trend
-24.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-103.4% in FY2022.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, return on assets (roa) decreased 24.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.36 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -103.4% | -24.6% |
| FY2021 | -83.0% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026